Tribe Capital Growth Corp I Uncategorized Contracts & Agreements
24 Contracts & Agreements
- Seventh Amendment to Business Combination Agreement, dated as of December 26, 2024, by and among the Company, Iris Parent Holding Corp. and Liminatus Pharma, LLC (Filed With SEC on December 27, 2024)
- Fifth Amendment to Business Combination Agreement, dated as of August 16, 2024, by and among the Company, Iris Parent Holding Corp. and Liminatus Pharma, LLC (Filed With SEC on November 27, 2024)
- Sixth Amendment to Business Combination Agreement, dated as of October 23, 2024, by and among the Company, Iris Parent Holding Corp. and Liminatus Pharma, LLC (Filed With SEC on November 6, 2024)
- Fourth Amendment to Business Combination Agreement, dated as of July 19, 2024, by and among the Company, Iris Parent Holding Corp. and Liminatus Pharma, LLC (Filed With SEC on July 25, 2024)
- Third Amendment to Business Combination Agreement, dated as of March 9, 2024, by and among the Company, Iris Parent Holding Corp. and Liminatus Pharma, LLC (Filed With SEC on April 17, 2024)
- Second Amendment to Business Combination Agreement, dated as of August 14, 2023, by and among the Company, Iris Parent Holding Corp. and Liminatus Pharma, LLC (Filed With SEC on April 17, 2024)
- Third Amendment to Business Combination Agreement, dated as of March 9, 2024, by and among the Company, Iris Parent Holding Corp. and Liminatus Pharma, LLC (Filed With SEC on April 5, 2024)
- Administrative Support Agreement, dated February 26, 2024 (Filed With SEC on March 12, 2024)
- Second Amendment to Business Combination Agreement, dated as of August 14, 2023, by and among Iris Acquisition Corp, Iris Parent Holding Corp. and Liminatus Pharma, LLC (Filed With SEC on August 28, 2023)
- Amendment to Business Combination Agreement, dated as of June 1, 2023, by and among the Company, Iris Parent Holding Corp. and Liminatus Pharma, LLC (Filed With SEC on August 28, 2023)
- Sponsor Forfeiture Agreement, dated November 30, 2022, by and between Iris Acquisition Holdings LLC and Iris Acquisition Corp (Filed With SEC on December 1, 2022)
- Lock-Up Agreement, dated November 30, 2022, by and among Iris Parent Holding Corp., Iris Acquisition Holdings LLC, Consonatus LLC, Car-Tcellkor Inc., Curis Biotech Holdings LLC... (Filed With SEC on December 1, 2022)
- Sponsor Support Agreement, dated November 30, 2022, by and among Iris Acquisition Corp, Liminatus Pharma, LLC and Iris Acquisition Holdings LLC (Filed With SEC on December 1, 2022)
- Description of Securities (Filed With SEC on April 18, 2022)
- Letter Agreement between the Registrant and Tribe Arrow Holdings I LLC (Filed With SEC on August 16, 2021)
- PIPE Commitment Agreement, dated March 4, 2021, by and between the Company and Arrow Capital (Filed With SEC on March 10, 2021)
- Letter Agreement, dated March 4, 2021, by and among the Company, its officers, its directors and the Sponsor (Filed With SEC on March 10, 2021)
- Form of Letter Agreement among the Registrant, Tribe Arrow Holdings I LLC and each of the executive officers and directors of the Registrant (Filed With SEC on February 26, 2021)
- Specimen Unit Certificate (Filed With SEC on February 26, 2021)
- PIPE Commitment Agreement between the Registrant and Arrow Capital (Filed With SEC on February 5, 2021)
- Form of Administrative Support Agreement between the Registrant and Tribe Capital Markets LLC (Filed With SEC on February 5, 2021)
- Form of Indemnity Agreement (Filed With SEC on February 5, 2021)
- Form of Letter Agreement among the Registrant, Tribe Arrow Holdings I LLC and each of the executive officers and directors of the Registrant (Filed With SEC on February 5, 2021)
- Specimen Unit Certificate (Filed With SEC on February 5, 2021)
